Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
230.63
+0.31 (0.13%)
At close: Dec 29, 2025, 4:00 PM EST
230.57
-0.06 (-0.03%)
After-hours: Dec 29, 2025, 7:21 PM EST
Danaher Market Cap
Danaher has a market cap or net worth of $162.91 billion as of December 29, 2025. Its market cap has decreased by -3.75% in one year.
Market Cap
162.91B
Enterprise Value
179.53B
1-Year Change
-3.75%
Ranking
Category
Stock Price
$230.63
Market Cap Chart
Since December 1, 1998, Danaher's market cap has increased from $6.13B to $162.91B, an increase of 2,559.51%. That is a compound annual growth rate of 12.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 162.69B | -1.88% |
| Dec 31, 2024 | 165.80B | -3.01% |
| Dec 29, 2023 | 170.94B | -11.53% |
| Dec 30, 2022 | 193.22B | -17.82% |
| Dec 31, 2021 | 235.10B | 48.98% |
| Dec 31, 2020 | 157.80B | 43.14% |
| Dec 31, 2019 | 110.24B | 52.53% |
| Dec 31, 2018 | 72.28B | 11.94% |
| Dec 29, 2017 | 64.57B | 19.92% |
| Dec 30, 2016 | 53.84B | -15.41% |
| Dec 31, 2015 | 63.65B | 5.68% |
| Dec 31, 2014 | 60.23B | 11.90% |
| Dec 31, 2013 | 53.82B | 39.00% |
| Dec 31, 2012 | 38.72B | 19.93% |
| Dec 30, 2011 | 32.29B | 4.66% |
| Dec 31, 2010 | 30.85B | 27.69% |
| Dec 31, 2009 | 24.16B | 33.51% |
| Dec 31, 2008 | 18.09B | -33.56% |
| Dec 31, 2007 | 27.23B | 22.14% |
| Dec 29, 2006 | 22.30B | 29.74% |
| Dec 30, 2005 | 17.19B | -3.00% |
| Dec 31, 2004 | 17.72B | 25.76% |
| Dec 31, 2003 | 14.09B | 40.70% |
| Dec 31, 2002 | 10.01B | 16.16% |
| Dec 31, 2001 | 8.62B | -11.14% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 969.72B |
| Johnson & Johnson | 501.76B |
| AbbVie | 408.83B |
| UnitedHealth Group | 297.85B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.10B |
| Novo Nordisk | 232.28B |